54 related articles for article (PubMed ID: 15950766)
21. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
22. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H
Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
[TBL] [Abstract][Full Text] [Related]
23. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY
Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663
[TBL] [Abstract][Full Text] [Related]
24. Association between the functional polymorphism in the matrix metalloproteinase-7 promoter and susceptibility to adult astrocytoma.
Lu Z; Wang Y; Zhang Q; Zhang X; Wang S; Xie H; Li Y; Jiao B; Zhang J
Brain Res; 2006 Nov; 1118(1):6-12. PubMed ID: 16956593
[TBL] [Abstract][Full Text] [Related]
25. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
26. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
Parhar P; Ezer R; Shao Y; Allen JC; Miller DC; Newcomb EW
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):98-103. PubMed ID: 15950766
[TBL] [Abstract][Full Text] [Related]
27. p53: guardian AND suppressor of longevity?
Donehower LA
Exp Gerontol; 2005; 40(1-2):7-9. PubMed ID: 15664727
[TBL] [Abstract][Full Text] [Related]
28. MAPK pathway activation and the origins of pediatric low-grade astrocytomas.
Tatevossian RG; Lawson AR; Forshew T; Hindley GF; Ellison DW; Sheer D
J Cell Physiol; 2010 Mar; 222(3):509-14. PubMed ID: 19937730
[TBL] [Abstract][Full Text] [Related]
29. Genetically engineered mouse models of astrocytoma: GEMs in the rough?
Reilly KM; Jacks T
Semin Cancer Biol; 2001 Jun; 11(3):177-91. PubMed ID: 11407943
[TBL] [Abstract][Full Text] [Related]
30. Mouse models with modified p53 sequences to study cancer and ageing.
Clarke AR; Hollstein M
Cell Death Differ; 2003 Apr; 10(4):443-50. PubMed ID: 12719721
[TBL] [Abstract][Full Text] [Related]
31. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies.
Zhao L; Zhao X; Wu X; Tang W
Genet Test Mol Biomarkers; 2013 Oct; 17(10):721-6. PubMed ID: 23844939
[TBL] [Abstract][Full Text] [Related]
32. Genetic alterations associated with adult diffuse astrocytic tumors.
Shapiro JR
Am J Med Genet; 2002 Oct; 115(3):194-201. PubMed ID: 12407701
[TBL] [Abstract][Full Text] [Related]
33. Alterations of the p53 and pRB pathways in human astrocytoma.
Rutka JT; Akiyama Y; Lee SP; Ivanchuk S; Tsugu A; Hamel PA
Brain Tumor Pathol; 2000; 17(2):65-70. PubMed ID: 11210173
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
